BCLI

BRAINSTORM CELL THERAPUTC
BCLI

Overview Fund Activity
Delisted

BCLI was delisted on the 17th of July, 2025.

Back to rankings

42 hedge funds and large institutions have $17.1M invested in BRAINSTORM CELL THERAPUTC in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 9 closing their positions.

Holders
42
Holders Change
-6
Holders Change %
-12.5%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
13
Reduced
9
Closed
9
Calls
$3.65M
Puts
$435K
Net Calls
+$3.22M
Net Calls Change
+$1.08M

Top Buyers

1
RJA
1
Raymond James & Associates
Florida
$1.08M
2
TIAM2
2
Tru Independence Asset Management 2
Oregon
$194K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$246K
4
Millennium Management
4
Millennium Management
New York
$634K
5
Creative Planning
5
Creative Planning
Kansas
$136K

Top Sellers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$0
2
IC
2
Ikarian Capital
Texas
$839K
3
SCFS
3
S.C. Financial Services
Arizona
$0
4
Group One Trading
4
Group One Trading
Illinois
$0
5
VF
5
Virtu Financial
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
WIM
51
Westside Investment Management
California
$0 200 – –
MSFP
52
Mark Sheptoff Financial Planning
Connecticut
$0 100 – –
CFGS
53
Concourse Financial Group Securities
Alabama
– – – –
1 2
3